Creating Digital Biomarkers with Real-World and Existing Data
XTalks
Archivio
02.02.2023 1235 Bay Street Suite 802, M5R 3K4 Toronto, Canada
Temi della conferenza
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. Validating a digital biomarker can be a huge task.
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. Validating a digital biomarker can be a huge task.
Professional congress organizer (PCO)
Dryfta
Dryfta
Informazioni ed Iscrizioni:
Mr. Andrew Juurinen
Farmacologia e Tossicologia
Lingua
Inglese
Inglese
Quote del Congresso
Ingresso libero
Ingresso libero
I partecipanti attesi
150
150
Contatto organizzatori
Suite B2,
19702 Newark
USA
Suite B2,
19702 Newark
USA
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
